In Drosophila, maternal string mRNAs are stable for the first few hours of development, but undergo specific timed degradation at the cellularisation stage. To determine whether the proteins that control this degradation are maternally or zygotically transcribed, we have used in situ hybridisation to determine the fate of maternal string transcripts in mutant embryos which lack individual chromosome arms. Our data indicate that maternal string mRNA persists for the normal period in all these mutants. Using oamanitin to inhibit zygotic transcription we have shown that degradation of maternal mRNA is unaffected. Therefore, the proteins required to activate the degradation of string mRNA are encoded on a maternally contributed mRNA. We discuss possible models to explain the degradation pathway.
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Introduction
Early Drosophila development is programmed by maternally contributed mRNAs. The majority of these mRNAs are stable for the first few hours of development but degrade prior to cellularisation (2.5 h after fertilisation) (Akam, 1987) . The degradation of these maternal developmental RNAs is specific, as other mRNAs such as rp49 and rus are stable over this period (Edgar et al., 1986) . In other organisms, for example Xenopus and the mouse, degradation of maternal developmental RNAs also occurs at a particular stage in early development (Bouvet et al., 1991; Jackson, 1993) . Since this pattern of specific, timed degradation is evolutionarily conserved, it is likely to be of critical importance in developmental programmes.
The stability of a particular RNA depends on its susceptibility to ribonucleases. The ribonucleases that have been characterised fall into two main groups: exonucleases and endonucleases. In eukaryotes, exonul Corresponding author, Tel.: +44 1705 842056; Fax: +44 I705 842053. cleases degrade RNA processively either from the 5 ' end (XRNl in yeast; Muhlrad et al., 1994) or the 3 ' end (human histone H4; Ross and Kobs, 1986) . Endonucleases cleave mRNA at specific sites and are thought to be the rate limiting step in decay of many transcripts .
In many eukaryotic systems, stability of a particular RNA is controlled by factors which change the susceptibility of that RNA to ribonucleases . Regulation of stability by proteins masking ribonuclease cleavage sites appears to be relatively common. For example, the human transferrin receptor mRNA has been shown to bind a protein factor to palindromes at its 3 ' end. Binding activity is inversely correlated with iron levels resulting in higher amounts of receptor when iron levels are low. It is likely that this protein factor selectively stabilises human transferrin receptor RNA by protecting sites from endonucleolytic attack (Mtillner et al., 1989) .
Translation also plays an important role in control of RNA stability. Instability of c-myc mRNA appears, in part, to be mediated by translation proceeding through a particular sequence at the 3 ' end of the coding region (Herrick and Ross, 1994) . The RNA instability conferred by the AUUUA motif of GM-CSF (human granulocyte/monocyte colony stimulating factor) requires the mRNA to be actively translated and the AU motif to be in the 3' untranslated region. It has been proposed that RNA stability mediated by the AU motif is achieved through translation-dependent assembly of a large mRNA destabilising complex (Savant-Bhonsale and Cleveland, 1992) .
There is increasing evidence that degradation, translation and polyadenylation are linked (Jackson and Standart, 1990; Jackson, 1993; Wellington et al., 1993 , Sachs, 1993 . Many observations suggest that factors such as cis-acting determinants in the 3 ' UTR that promote degradation do so by facilitating rapid deadenylation followed by decapping and exonucleolytic decay. Since the rate of each step of this pathway can be controlled by proteins complexed to the RNA, there are many ways in which the degradation rate of a particular RNA can be modulated .
Although the mechanisms controlling RNA degradation in human tissue culture cells and in yeast are beginning to be understood, very little is known about control of RNA degradation in Drosophila. Because Drosophila maternal mRNAs undergo a specific, timed degradation, they provide an excellent model system in which to study the degradation process. The maternal RNAs (e.g. bicoid, dorsal, cyclinB), which encode proteins critical in the early developmental programme of the embryo, are synthesised in the nurse cells of the ovary and are transported via the anterior of the oocyte prior to fertilisation. After fertilisation, there are 13 nearlysynchronous nuclear divisions before cell walls form around the nuclei of the developing embryo. At cycle 14 (about 2.5 h after fertilisation), cellularisation of the embryo occurs and gastrulation follows. The majority of zygotic transcription commences at cycle 14 and zygotic products then complete the developmental programme. All of those maternal mRNAs which control early development and have been studied to date are stable during early nuclear divisions, but degrade prior to completion of cellularisation at cycle 14 (reviewed in Akam, 1987; Ingham, 1988) .
To understand the mechanisms controlling degradation of maternal mRNAs in Drosophila, it is first necessary to determine whether the proteins controlling the degradation are zygotically transcribed or are maternally contributed.
Since maternal mRNAs are degrading over the period in which the first zygotic mRNAs are transcribed, it would seem likely that the RNase (or proteins controlling the RNase) would be activated or produced by zygotic transcription. In this paper, we have used two independent approaches to determine whether the degradation of maternal mRNAs is controlled maternally or zygotically. Possible mechanisms to explain the control of this degradation are then discussed.
Results

Degradation pattern of string mRNA in wild-type embryos
The maternal mRNA chosen for this analysis was string. String is known to be a tyrosine phosphatase involved in the initiation of mitosis and is homologous to cdc25 of Schizosaccharomyces pombe. Expression of string is well characterised and, like many other developmental genes, is transcribed both maternally and zygotically. String mRNA is expressed maternally and is present over the entire embryo. It is degraded at interphase of cycle 14 but is then expressed zygotically in tissues that are about to undergo mitosis .
The degradation pattern of string mRNA in wild-type embryos was analysed in detail (Fig. 1) . String transcripts were detected by anti-sense probes which included 1439 nucleotides of coding region and 776 nucleotides of 3 ' untranslated region, labelled with digoxigenin (See Experimental procedures). Early string transcripts are abundant (Fig. 1A) and are displaced by the yolk as the nuclei migrate to the periphery of the embryo. As cellularisation proceeds, string transcripts are degraded (Fig. 1B) and when cellularisation is completed there is no trace of the string message (Fig. 1C) . At early gastrulation (stage 6), zygotic transcripts appear in a number of defined patches (Fig. 1D ).
2.2. Aneuploid screen for zygotically expressed regulators of string mRNA degradation
The strategy used was based on the approach devised by Merrill et al. (1988) and Wieschaus and Sweeton (1988) to search for zygotic regulators of early events in embryogenesis. The technique employs compound chromosome stocks to generate embryos lacking specific chromosome arms. Since the phenotype of the maternal parent is wild-type, early development programmed by maternal RNAs can proceed normally. However aneuploid embryos start to display various defects around cellularisation when zygotic products are required. This technique can be used to identify zygotic regulators of early developmental processes and map them to particular chromosomal arms (Vavra and Carroll, 1989; Merrill et al., 1988) .
To determine whether genes controlling maternal string RNA degradation are located on the Xchromosome or on autosomes 2 or 3, we examined the pattern of transcript decay in embryos aneuploid for each chromosome arm ( Fig. 2A and B) . We reasoned that if the proteins controlling maternal string RNA degradation are located on, for example, the right arm of chromosome 3, then in the mutants lacking this chromosome arm the controlling genes will be absent, resulting in delayed or premature degradation of maternal string transcripts. If the gene or genes controlling maternal mRNA degradation are maternally transcribed, we Fig. 1 . Spatial and temporal distribution of maternal string transcripts in early wild type Drosophila embryos. Whole mount in situ hybridisation was carried out using a digoxigenin labelled antisense RNA probe (Tautz and Pfeifle, 1989, Shishido et al., 1993) . would expect string mRNA to degrade in the wild type pattern in the mutant embryos.
2.3. Degradation of maternal string mRNA in embryos lacking the entire X-chromosome Embryos with no X-chromosome were obtained as the progeny of females carrying an attached-X chromosome and a normal Y-chromosome ( Fig. 2A , ). Nullo-X embryos are normal in their development until cycle 14, but then fail to cellularise correctly. They can be recognised by their failure to develop a regular actin lattice resulting in irregular spacing between the nuclei .
Embryos were collected and the maternal string transcripts visualised by antisense RNA probes. A number of embryos at different stages throughout syncytial and cellular blastoderm and early gastrulation were examined. As cellularisation proceeds the string transcript disappears until none is visible ( Fig. 3A and B), The pattern of maternal string mRNA decay in these embryos is therefore identical to that of wild-type embryos. After cellularisation, string transcripts are expressed zygotically (Fig. 3C ) in a different pattern to that of wild type. Deletion of genes on the Xchromosome must therefore perturb the correct zygotic expression of string. These results show that genes controlling degradation of maternal string mRNA are either not located on the X-chromosome, or the degradation regulators may be controlled zygotically by the products of 2 or more different genes situated on the Xchromosome and on an autosome which can complement each other.
Degradation pattern of maternal string mRNA in embryos aneuploid for each autosomal arm
To determine whether degradation of string mRNA is controlled by genes on chromosome 2 or 3, we used aneuploid embryos deficient for each of the autosomal chromosome arms (Merrill et al., 1988) . These mutant embryos are generated by crossing parental flies bearing compound chromosomes which have both left arms and both right arms of a chromosome joined at the centromere. This cross produces embryos, 25% of which lack left chromosome arms (2L-or 3L-), 25% of which lack right chromosome arms (3L-and 3R-), while the remaining 50% are at least diploid with respect to each arm (Fig. 2B ). The phenotypes of these embryos have been characterised in detail (Merrill et al., 1988) .
Embryos from the compound chromosome crosses were collected and the mutants recognised using the criteria of Merrill et al. (1988) . A large number of mutants at a range of stages throughout syncytial blastoderm, cellularisation and early gastrulation were examined. Results for 2L-mutants ( Fig. 3D and E ), 3L-( Fig. 4A and B) and 3R-( . (B) Embryos deficient for the left or right arms of chromosome 2 were generated using compound autosome stocks. These individuals have both left arms attached to one centromere and both right arms attached to the other centromere. Of the resulting progeny, 25% have no right arm of the attached autosome and 25% have no left arm of that autosome. The remaining progeny are phenotypically normal. Embryos deficient for the left and right arms of chromosome 3 are produced in a similar fashion. (Merrill et al., 1988) .
tern of degradation of maternal string mRNA to that of the wild-type: we could find no evidence of delayed or premature degradation of the maternal string transcript. For 2L-and 3L-mutants, zygotic string is expressed, but in a different pattern to that of the wild-type ( Fig.  3F and 4C) . Therefore, there must be regulatory genes on the left arms of chromosomes 2 and 3 which affect the expression of zygotic string mRNA. The 3R-mutants have the usual pattern of maternal transcript decay but fail to show any zygotic staining (Fig. 4F) as the string gene is located on the right arm of chromosome 3. Distinguishing the 2R-mutants from wild type at the cellularisation stage is very difficult as the phenotype only becomes apparent during gastrulation. However, if the maternal string mRNA was significantly stabilised over this period in the 2R-mutants, this would have been apparent from examination of all embryos around the cellularisation stage. No differences in the hybridisation pattern were seen. These results demonstrate that the removal of whole chromosome arms is insufftcient to perturb maternal string degradation. Thus, the degradation regulator may be produced or controlled zygotically by the products of two or more different genes situated on different chromosomes or chromosomal arms which can substitute for each other. Alternatively, the proteins controlling maternal string mRNA degradation are not zygotically produced and therefore must be translated from maternal mRNAs.
Effect of cr-amanitin on degradation of maternal mRNAs
In order to distinguish between the above two hypotheses, early embryos were treated with the transcription inhibitor cy-amanitin. If the protein controlling maternal mRNA degradation is encoded by zygotic RNA, then (Yamanitin will inhibit the transcription of this mRNA and we would expect maternal transcripts to be stabilised at cellularisation. If the regulatory protein is translated from maternally contributed transcripts, we would expect maternal RNAs to follow the wild type pattern and be degraded at cellularisation.
One hundred and fifty wild type embryos were collected and those that had developed beyond the pre-pole cell stage (cycle 9) discarded. The embryos were incubated in cr-amanitin (8 pg/ml) until the cellularisation stage (cycle 14), then RNA was extracted from the embryos, electrophoresed on a formaldehyde gel and transferred to nylon filters (see Experimental procedures). The concentration of cY-amanitin used was sufficient to prevent further development of the embryos after cycle 14 (data not shown). RNA was also extracted from pre-cellularisation (cycle 9) and post-cellularisation (cycle 14) embryos which had not been treated with ar-amanitin. String RNA was then detected by Northern hybridization using radio-labelled DNA probes. To determine the effect of a-amanitin on other maternal transcripts, the Northern blots were then sequentially hybridised with probes for cyclinB and bicoid (see Experimental procedures). CyclinB is homologous to cdcl3 of Schizosaccharomyces pombe and was chosen because the bulk of maternal mRNA is also known to degrade at cellularisation. The cyclinB mRNA is con- Fig. 3 . Spatial and temporal distribution of string transcripts in nullo-X embryos and embryos deficient for the left arm of chromosome 2. (A and B) Nullo-X embryos at cellularisation, during invagination of the cell membrane (A) and when invagination is completed (B). Embryos were distinguished by the irregularity of their cell size due to defects in their F-actin lattice organisation . (C) Nullo-X embryos showing zygotically transcribed string mRNA. The zygotic transcription pattern is different from that of the wild type because of the lack of Xchromosomal genes. (D and E) 2L-embryos during cycle 14 at equivalent stages to (A) and (B). Embryos were distinguished by their threelayered 'halo' appearance due to their failure to transport lipid droplets basally in the cytoplasm. These embryos fail to cellularise properly (Merrill et al. 1988) . (F) Zygotic expression pattern of string in the 2L-embryos. centrated around the nuclei of the syncytial embryo suggesting that the transcript is associated with microtubules (Raff et al., 1990) . Bicoid is a maternally contributed mRNA that is fundamental in the control of anterior-posterior pattern formation. The bicoid RNA is trapped at the anterior end of the embryo by proteins associated with microtubules. It remains present in the cortical plasm throughout early cleavage stages, and then disappears after the last cleavage divisions during the period of nuclear elongation (Berleth et al., 1988) . Finally, the Northern blots were probed with various control mRNAs. Ribosomal RNAs and rp49 RNAs are abundantly expressed, stable RNAs in the early embryo and were used as internal loading controls. To check that cr-amanitin was inhibiting zygotic transcription, histone H3 RNAs, which are both maternally and zygotically expressed (Andersen and Leyngel, 1980) and Krtlppel mRNAs, which are exclusively zygotically expressed (Gaul et al., 1987) , were detected (see Experimental procedures).
In untreated embryos, maternal string mRNA is present prior to cellularisation but is degraded at cycle 14 (Fig. 5A) . The faint band visible at cycle 14 is due to zygotic transcription: the time between degradation of maternal string mRNA and onset of zygotic transcription is so short that even though accurate staging was attempted, some embryos have commenced zygotic transcription. CyclinB and bicoid mRNA are present at cycle 9 but have completely degraded at cycle 14. Therefore, the degradation profile of these RNAs Fig. 4 . Spatial and temporal distribution of string transcripts in embryos deficient for the left arm and right arms of chromosome 3. (A) 3L-embryos at cellularisation, during invagination of the cell membrane (A) and when invagination is completed (B). Embryos were identified by their 'fuzzy' appearance due to their failure to transport nuclei correctly to the periphery (Merrill et al., 1988) . (C) Zygotic expression pattern of string in 3L-embryos during their attempt at gastrulation. (D) 3R-embryos during cellularisation and (E) when attempted cellularisation is completed. These embryos were identified by their constricted nuclei where the invaginating cell membranes close together prematurely (Schejter and Wieschaus, 1993) . (F) 3R-embryo after attempting celluiarisation. Zygotic string transcripts are not visible as the string gene is located on the right arm of chromosome 3.
follows a pattern consistent with data given above and with published work (Berleth et al., 1988; Raff et al., 1990) . In embryos treated with cr-amanitin, string, cyclinB and bicoid maternal mRNAs are not visible at cellularisation. Control rp49 and ribosomal RNAs are present in all tracks, indicating that lack of hybridisation was not due to extraction conditions or degradation of the RNA. Histone H3 mRNA is present maternally and zygotic transcripts are detected in untreated embryos at cycle 14 as expected (Andersen and Leyngel, 1980) . However, for embryos treated with cr-amanitin, these transcripts are not detected, indicating that the concentration of the drug was sufficient to inhibit zygotic transcription. Zygotic Krtippel mRNA (Fig. 5 ) is detected at cellularisation in the untreated embryos but not in the embryos treated with cr-amanitin, again showing that treatment with cr-amanitin was effective.
These results, taken together with the above experiments using embryos lacking individual chromosomes or chromosomal arms, show that the protein responsible for the degradation of developmentally important RNAs does not require zygotic transcription.
Discussion
Comparison of control of maternal degradation with that of other organisms
In this paper, we have used two very different approaches to show that degradation of maternal mRNAs at cellularisation does not appear to be initiated by new embryonic transcripts and, therefore, is most likely to be controlled by proteins encoded on maternally contributed RNAs. Results obtained are consistent with previously published work which shows that Drosophila Kru;prl (2.5kb) Fig. 5 . Northern blot analysis of embryos treated with the transcription inhibitor a-amanitin. Early embryos (cycle 9) were incubated in o-amanitin as described in Experimental procedures. Control embryos were incubated in media alone. Total RNA was extracted and analysed on Northern blots by sequentially hybridising with radio-labelled probes. In control embryos, string, cyclinB and bicoid mRNAs are present prior to cellularisation (lane 1) and are degraded at cycle 14 (lane 2). The traces of string mRNA that are detected at cellularisation are due to zygotic transcription. In a-amanitin treated embryos (lane 3), maternal string, cyclinB and bicoid mRNAs are degraded at celhtlarisation. Control rp49 transcripts and ribosomal RNAs are stable throughout. Histone H3 mRNAs are present maternally and zygotically in control embryos but are absent in a-amanitin treated embryos. Knippel mRNA is zygotically transcribed (Gaul et al., 1987) : the absence of Ktippel transcripts in a-amanitin-treated embryos shows that the concentration of cw-amanitin used was sufftcient to inhibit zygotic transcription. development prior to cellularisation does not require zygotic products . These results are similar to those obtained using Xenopus embryos, where the degradation of maternal transcripts after midblastula transition requires translation of another maternal mRNA (Bouvet et al., 1991) .
Control of the timing of maternal mRNA degradation
How is the timing of maternal string RNA degradation controlled? One possible method by which the degradation could be triggered at the correct moment would be if it were linked to the number of mitotic cycles. Once a sufficient number of rounds of mitosis have taken place, the degradation pathway could be activated to remove all maternal signals thereby allowing the majority of zygotic transcription and expression to begin.
A mechanism to explain the cell cycle timing at successive stages of Drosophila embryogenesis has been proposed (Edgar et al. 1994) . By immunoblotting to accurately staged embryos it has been shown that levels of String protein decline gradually from cycle 8 with complete degradation at the interphase of cycle 13. This leads to inhibitory phosphorylation of Cdc2 and cell cycle arrest. Subsequently, mitoses 14-16 are triggered by pulses of zygotic string transcription (Edgar et al., 1994) . It is possible that the programmed degradation of String protein also triggers a pathway that induces degradation of string and other maternal RNAs.
Specificity of degradation of maternal RNAs
We have also examined the degradation of cyclinB transcripts in embryos deficient for each of the chromosomal arms. The degradation pattern is similar to that of the wild type embryos (data not shown). Therefore, stability of cyclinB mRNA also appears to be controlled by maternal factors. What are the features of maternal RNAs such as string, cyclinB and bicoid that confer specificity to degradation? We have shown that rp49 transcripts (this paper) are stable over the cellularisation period. In other organisms, susceptibility to cleavage by ribonucleases is often conferred by cis-acting elements within the mRNA. In Xenopus, the sequence motif(s) which confer instability on one of these developmentally regulated mRNAs, Eg2, is contained within a 497-bp fragment (Bouvet et al. 1991) . Cis-acting elements comprising RNA secondary structures or repeated motifs have been found to confer specificity to ribonucleases in many other systems (Brawerman, 1989) .
Proposed models to explain degradation of maternal RNAs
Three models are proposed to explain degradation of string and other maternal mRNAs (Fig. 6) .
(1) A degradation regulator (e.g an RNase) could be translated from maternally contributed RNA very early 1995) 217-226 in embryogenesis in an inactive form. This regulatory factor is activated prior to cellularisation and in turn activates a degradation pathway specific to particular maternal mRNAs. Alternatively, the degradation regulator could be translated in an active form just prior to cycle 14. Other RNAs such as rp49 are presumably not degraded because they are not recognised by the proteins regulating the degradation pathway.
(2) The maternal mRNAs are protected from degradation by ribosomes or by other non-specific proteins which block access of RNases to ribonuclease cleavage sites. At the cellularisation stage, translation is inhibited, the ribosomes fall off and specific sites within the maternal mRNAs become accessible to RNases. The rp49 RNAs either do not have these specific cleavage sites, or translation is not blocked at cellularisation. (3) Maternal mRNAs are normally protected from degradation by being bound to specific protein factors which protect the RNA from degradation. The protein factors are removed by a regulatory cascade at cellularisation, exposing the maternal RNA to ribonucleases. The control rp49 mRNAs which do not degrade may either not be recognised by these RNases or the protein factors may remain bound. In Xenopus, it has been suggested that a trans-acting factor involved in mRNA stability is synthesised just before mid-blastula transition, when many mRNAs degrade, This was proposed because treatment of embryos with the translation inhibitor cycloheximide caused stabilisation of maternal Eg transcripts (Duval et al., 1990; Bouvet et al., 1991) , suggesting that translation of a labile RNase was blocked. However, the action of cycloheximide is not well understood, and it may 'freeze' ribosomes on the transcript thus preventing access to ribonucleases (Pachter et al., 1987) or may inhibit the decapping reaction that follows deadenylation (Beelman and Parker, 1994) . Therefore, there is no direct evidence, in Xenopus, showing that proteins controlling Eg2 degradation are not present and active in the early embryo. We have injected in-vitro transcribed capped, polyadenylated string transcripts containing deletions into early embryos. These injected RNAs are extremely unstable, suggesting that early (cycle 9) embryos contain active ribonucleases (unpublished data). We therefore favour models [2] and [3] where an active ribonuclease is present throughout the development of the embryo, but maternal string mRNA is protected by being bound to a protein or other factors.
There is increasing evidence that translation and mRNA degradation are linked. In yeast, the prtl mutation leads to a decreased rate of translation initiation of heat-shock genes, resulting in increased fragmentation of the heat-shock transcripts. It has been proposed that decreased translocation of ribosomes unmasks a cisacting sequence element located near the translation start, allowing increased access to ribonucleases (Barnes et al., 1993) . In Drosophila, Nanos protein has been shown to bind to regulatory sequences in the 3 'UTR of hunchback RNA and block translation of maternal hunchback in the early embryo. The untranslated hunchback message is then rapidly degraded leading to the observed localisation of hunchback product (Wharton and Struhl, 1991) .
If the translocation of ribosomes along the string transcript is occluding ribonuclease sites, we would expect cessation of translation to immediately precede degradation. However, immunoblotting of very small numbers of precisely staged embryos has shown that String protein declines from cycle 8 and is absent at cycle 13, when string mRNA is still present (Edgar et al., 1994) . Therefore, either cessation of translation does not directly facilitate degradation or there is a lag period between inhibition of translation and degradation.
There are various examples of control of RNA stability being mediated by sequence specific binding proteins (Brewer and Ross, 1989; You Yun et al., 1992; Bernstein et al., 1992) . Drosophila embryo lysates have been shown to contain a specific endoribonuclease activity and a protective factor capable of recognising Xenopus endonuclease sites. (Brown et al., 1993) . Control of RNA stability by protection of the RNA from ribonucleases has also been shown for Drosophila Hsp83 transcripts. These transcripts which are expressed in the early embryo become localised at the posterior pole by generalised degradation of Hsp83 transcripts throughout the embryo and local protection of Hsp83 mRNA at the posterior pole. A 406-nucleotide cis-acting element in the 3' UTR of Hsp83 has been shown to confer protection of the maternal Hsp83 transcripts from degradation. In mutants that eliminate polar granules, (e.g. cappuccino, spire, oskar) maternal Hsp83 RNA is not protected from degradation at the posterior pole. Therefore, some component of the polar plasm or polar granules appears to bind to the cis-acting UTR and protect the RNA against degradation (Ding et al., 1993) .
While there are good precedents for explaining the control of maternal string degradation in terms of binding to protective proteins or ribosomes, identification and characterisation of the proteins and specific RNA sequences involved in degradation of string and other maternal RNAs will be required before the control of this degradation pathway is understood. compound third chromosome (Merrill et al., 1988) . Attached-X virgin females were crossed with wild type males to produce nullo-X embryos. Embryos were collected at 25°C on yeasted apple juice plates and aged for the appropriate period of time at 25°C. They were then dechorionated in 3% sodium hypochlorite, fixed for 20 min in 4% formaldehyde PBS before devitellinisation in methanol/EGTA and storage at -20°C in methanol.
Whole mount in-situ hybridisation of Drosophila embryos
Wild type and mutant embryos were collected and subjected to in-situ hybridisation using digoxigeninlabelled (DIG) anti-sense RNA probes. The method of Tautz and Pfeifle (1989) was used with the modifications described in Shishido et al., (1993) .
The anti-sense string RNA probe was generated by linearising pLAstg, which carries a 2.6-kb string cDNA, with BstBl and transcribing with T7 polymerase according to the manufacturer's instructions (BoehringerMannheim RNA labelling kit no. 1175025).
Embryos were stained as described by the manufacturer's instructions (Boehinger-Mannheim kit no. 1175041, blue stain) and mounted in JB-4 methacrylate (Polysciences).
Treatment of embryos with ol-amanitin
Embryos were dechorionated and those which had passed cycle 9 discarded. They were then permeabilised in heptane for 2 min, rinsed in TClOO insect tissue culture medium (BRL) and then incubated in ar-amanitin (8 &nl) in TClOO medium until cellularisation had commenced. Control embryos were incubated in TClOO medium alone. The TClOO medium was then removed from both sets of the embryos which were then rinsed twice in 1 x PBS buffer.
RNA extraction and Northern blotting
Embryos were lysed using REB lysis buffer (8M Urea, 0.35M NaCl, 10 mMTris pH 8.3, 10 mM EDTA) in a mini-homogeniser. The lysate was then extracted with phenol/chloroform, again with chloroform and the nucleic acids were precipitated with ethanol. The pellets were then washed with 70% ethanol, resuspended in RNase free water and treated with DNasel (Pharmacia) according to the manufacturer's instructions.
1 pg RNA samples were electrophoresed in formaldehyde gels essentially as described by Sambrook et al., (1989) except that gels were made up in sodium phosphate buffer (1 mM) and the gels were electrophoresed in 10 mM sodium phosphate buffer with recirculation. RNA was then transferred to nylon filters (Biodyne A, Pall) and fixed using W crosslinking. RNA transcripts were detected using DNA probes labelled using the Amersham 'Megaprime' kit (no. RPN1606), as described by the manufacturer. Hybridisation was at 68°C in 'Quickhyb' (Stratagene) with a probe concentration of 10 @ml. Final wash conditions were 0.2 x SSC, O.l%SDS. After autoradiography, the probe was stripped from the filter by washing in 0.1% S.D.S at 90°C. The filter was then re-hybridised to subsequent probes. The experiments were repeated three times with similar results.
The DNA fragments used as probes used were: string: a 1-kb Pstl fragment from pLAstg (a gift from L. Alphey); cyclinB: a 2-kb EcoRV-Hind111 fragment from pCycB (gift from B. Dalby); bicoid a 2-kb EcoRV-Pstl fragment from c.53.46.6 (gift from W. Driever); rp49: a 300-bp EcoRl fragment from ~720; rRNA: a 1.2-kb BamHl fragment from pXL212 (gift from C. Read); histone H3: a 600-bp HindIII-Not1 fragment from pGB1; Kriippel: a 2-kb EcoRl genomic fragment (a gift from H. Jiickle). 
